The French National Authority for Health said on Thursday it has approved the vaccine developed by Pfizer and BioNTech for a nationwide roll-out, which can be used for people aged 16 and over.
Health workers and the elderly will be given priority when the vaccination campaign starts on Sunday, the government said.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3